WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.
WuXi AppTec Co., Ltd. has announced a plan to repurchase its RMB-denominated ordinary shares (A Shares) through bidding on the Shanghai Stock Exchange in 2025. This initiative aims to safeguard shareholder interests, enhance investor confidence, and align the market price of its shares with their intrinsic value. The repurchase, funded by the company’s own and raised funds, will lead to a reduction in registered capital. The plan requires shareholder approval and will be implemented over a period not exceeding twelve months, with provisions for early termination if certain conditions are met.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing a range of services including drug discovery, development, and manufacturing, catering to global pharmaceutical and healthcare companies.
YTD Price Performance: 14.16%
Average Trading Volume: 5,403,051
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$194.8B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.